REPORT OUTLOOK
Market Size | CAGR | Dominating Region |
---|---|---|
11.6 billion | 7.4% | North America |
by Product | by Condition | by End User |
---|---|---|
|
|
|
SCOPE OF THE REPORT
Neurodiagnostics Market Overview
The global neurodiagnostics market is expected to grow at 7.4% CAGR from 2019 to 2028. It is expected to reach above USD 11.6 billion by 2028 from USD 6.1 billion in 2019.
Neurodiagnostics examinations are typically administered to patients afflicted with central nervous system disorders, encompassing conditions affecting the brain and spinal cord. These assessments involve the monitoring and recording of electrical activity across the brain, spinal cord, and peripheral nerves, aiming for swift and precise disease diagnosis. Enhanced diagnostic insights can be achieved through specialized imaging techniques, facilitating the visualization of alterations in brain activity or specific chemical levels within the brain.
The escalating global prevalence of neurological and neurodegenerative ailments has spurred an augmented demand for accurate disease diagnosis. According to the World Health Organization, neurological disorders contribute to 12% of total global mortality, with an estimated 276 million individuals worldwide grappling with various afflictions such as Alzheimer’s disease, strokes, epilepsy, and migraines, among others. Anticipated to burgeon in the forthcoming years, the neurodiagnostics market holds promise for lucrative growth, propelled by the mounting incidence of neurological disorders and the imperative for early detection.
Manufacturers of diagnostic imaging technologies are investing in integrating advanced features into their modalities to enhance the precision of neurological disorder diagnoses. For example, Medtronic PLC’s Stealth Station S8 Neurosurgery System offers comprehensive visualization and surgical navigation capabilities throughout the spinal column. Equipped with cutting-edge technologies including 3D cameras, electromagnetic sensors, tracking algorithms, and data processing software, these advancements streamline the diagnostic process, driving the global neurodiagnostics market forward.
The World Health Organization (WHO) declared the COVID-19 outbreak a public health emergency of international concern, impacting approximately 210 countries worldwide. This unprecedented global health crisis is poised to adversely affect the neurodiagnostics market. The ramifications of the COVID-19 pandemic are expected to impede the neurodiagnostics industry significantly, primarily due to healthcare facilities’ prioritization of setting up COVID-19-specific intensive care units (ICUs) and the temporary cessation of neurodiagnostics device production and manufacturing activities in heavily affected regions across the globe.
Neurodiagnostics Market Segment Analysis
On the basis of product, the market is categorized into diagnostic & imaging systems, and in-vitro diagnostics (IVDs). The diagnostic & imaging systems segment is further divided into electroencephalogram (EEG) systems, magnetic resonance imaging (MRI) systems, ultrasound imaging systems, computed tomography (CT) scanner, and others. The in-vitro diagnostics (IVDs) is further segmented into molecular diagnostics and other IVDs.
The market, by condition, is segmented into neurodegenerative diseases, epilepsy, stroke, headache disorders, sleep disorders, and other conditions (includes autism, schizophrenia, Williams syndrome, Landau-Kleffner syndrome, depression, attention-deficit hyperactivity disorder (ADHD), and dyslexia). The neurodegenerative diseases segment is expected to account for the majority of the neurodiagnostics market in 2019. The rising prevalence of traumatic brain injuries, dementia, Parkinson’s disease, and Huntington’s disease, as well as the increasing number of neurological examinations performed to diagnose these conditions, are driving the growth of this market segment.
Based on end-user, the market is segmented into hospitals & surgical centers, diagnostic laboratories & imaging centers, neurology centers, ambulatory care centers (ACCs), and research laboratories & academic institutes. The neurodiagnostics market was dominated by hospitals and surgical centres. The large share of this end-user segment can be attributed primarily to hospitals’ financial ability to purchase expensive equipment, such as neurodiagnostic devices. Hospitals also have a greater number of trained professionals than any other end-user segment, which is a major factor driving market growth.
Neurodiagnostics Market Players
Some of the players in the neurodiagnostics market are GE Healthcare (US), Siemens Healthiness (Germany), Philips Healthcare (Netherlands), Canon, Inc. (Japan), Hitachi, Ltd. (Japan), Lifelines Neuro Company, LLC (US), Natus Medical Incorporated (US), Hoffman-La Roche AG (Switzerland), FUJIFILM Holdings Corporation (Japan), Mitsar Co., Ltd. (Russia), Advanced Brain Monitoring (US), Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories (US), QIAGEN N.V. (Netherlands), and Nihon Kohden Corporation (Japan) among others.
In the global market, GE Healthcare is the dominant player. In the market, the company provides various diagnostic imaging modalities and services for neurodiagnostic procedures. The company has been focusing on product launches, strategic agreements, and collaborations to maintain its leadership position and ensure future growth. In order to identify new product opportunities, the company also evaluates new, emerging, and complementary technologies.
Companies are mainly in the device manufacturing and they are competing closely with each other. Innovation is one of the most important and key strategy as it has to be for any health-related market.
However, companies in the market have also opted and successfully driven inorganic growth strategies like mergers & acquisition and so on.
- In February 2019, Philips Healthcare (Netherlands) launched the Incisive CT Platform and Ingenia Ambition 1.5T MRI System.
- In September 2018, Royal Philips entered into two 20-year agreements for managed equipment services, where it has agreed to provide delivery, optimization, replacement, and maintenance services for all major medical imaging solutions in Australia and the ASEAN Pacific region.
- In March 2018, GE Healthcare (US) launched its SIGNA Premier 3.0T magnetic resonance imaging (MRI) system in Canada
Who Should Buy? Or Key stakeholders
- Medical device manufacturers
- Implant Suppliers
- Pharmaceutical companies
- Investors
- Manufacturing companies
- End user companies
- Research institutes
- Hospitals
Neurodiagnostics Market Regional Analysis
The Global market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
- North America: includes the US, Canada, Mexico
- Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
- Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
- South America: includes Brazil, Argentina and Rest of South America
- Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA
Its major share is occupied by North America, Europe and Asia Pacific region. North America shares 33% of total market.
Key Market Segments: Neurodiagnostics Market
Global Market by Product, 2019-2028, (In USD Million)
- Diagnostic and Imaging Systems
- Electroencephalogram (EEG) Systems
- Electromyography (EMG) Products
- Magnetic Resonance Imaging (MRI) Systems
- Ultrasound Imaging Systems
- Computed Tomography (Ct) Scanner
- Magnetoencephalogram (Meg) System
- Position Emission Tomography (Pet) System
- Angiography System
- Other Systems
- Clinical Testing Instruments
- PCR
- Next-Generation Sequencing (NGS)
- Sanger Sequencing
- Other Clinical Diagnostic Products
- Reagents & Consumables
- Media and Serra
- Solvents
- Enzymes, Protein & Peptides
- Probes
- Buffers
- Antibodies
- Other Reagents
Global Market by Condition, 2019-2028, (In USD Million)
- Neuro Degenerative Diseases
- Epilepsy
- Stroke
- Headache Disorders
- Sleep Disorders
- Other Diseases
Global Market by End User, 2019-2028, (In USD Million)
- Hospitals and Surgery Centers
- Neurology Centers
- Ambulatory Care Centers
- Diagnostic Laboratories & Imaging Centers
- Research Laboratories & Academic Institutes
Global Market by Region, 2019-2028, (In USD Million)
- North America
- Europe
- Asia Pacific
- South America
- Middle East and Africa
Important Countries in All Regions Are Covered.
Key Question Answered
- What are the growth opportunities related to the adoption of neurodiagnostics products across significant regions in the future?
- Emerging countries have immense opportunities for the growth and adoption of diagnostic and imaging systems, clinical testing instruments, and related reagents & consumables. Will this scenario continue in the next five years?
- Where will the advancements in products offered by various companies take the industry in the mid- to long-term?
- What are the newest trends and advancements in the neurodiagnostics market?
- What will the market growth rate, growth momentum or acceleration the market carries during the forecast period?
Table of Content
-
- Introduction
- Market Definition
- Market Dynamics
- Market Segmentation
- Report Timelines
- Key Stakeholders
- Research Methodology
- Data Mining
- Secondary Research
- Primary Research
- Subject Matter Expert Advice
- Quality Check
- Final Review
- Data Triangulation
- Bottom-Up Approach
- Top-Down Approach
- Research Flow
- Data Mining
- Executive Summary
- Introduction
- Global Neurodiagnostics Market by Product
- Global Neurodiagnostics Market by Condition
- Global Neurodiagnostics Market by End User
- Global Neurodiagnostics Market by Region
- Market Dynamics
- Drivers
- Factors Helping in Growth of The Market
- Restraints
- Factors Affecting to The Market Growth
- Industry Value Chain
- Manufacturer
- Distributor
- End User
- Porter’s Five Forces Model
- Threat from New Entrants
- Threat from Substitutes
- Bargaining Power of Suppliers
- Bargaining Power of Customers
- Degree of Competition
- Drivers
- Neurodiagnostics Market by Product
- Introduction
- Diagnostic and Imaging Systems
- Electroencephalogram (EEG) Systems
- Electromyography (EMG) Products
- Magnetic Resonance Imaging (MRI) Systems
- Ultrasound Imaging Systems
- Computed Tomography (Ct) Scanner
- Magnetoencephalogram (Meg) System
- Position Emission Tomography (Pet) System
- Angiography System
- Other Systems
- Clinical Testing Instruments
- PCR
- Next-Generation Sequencing (NGS)
- Sanger Sequencing
- Other Clinical Diagnostic Products
- Reagents & Consumables
- Media and Serra
- Solvents
- Enzymes, Protein & Peptides
- Probes
- Buffers
- Antibodies
- Other Reagents
- Diagnostic and Imaging Systems
- Global Neurodiagnostics Market by Product
- Introduction
- Neurodiagnostics Market by Condition
- Introduction
- Neuro Degenerative Diseases
- Epilepsy
- Stroke
- Headache Disorders
- Sleep Disorders
- Other Diseases
- Global Neurodiagnostics Market by Condition
- Introduction
- Market by End User
- Introduction
- Hospitals and Surgery Centers
- Neurology Centers
- Ambulatory Care Centers
- Diagnostic Laboratories & Imaging Centers
- Research Laboratories & Academic Institutes
- Global Neurodiagnostics Market by End User
- Introduction
- Neurodiagnostics Market by Region
- Introduction
- Global Neurodiagnostics Market by Region
- North America
- Us
- Canada
- Mexico
- South America
- Brazil
- Argentina
- Colombia
- Rest of South America
- Asia-Pacific
- India
- China
- Japan
- South Korea
- Australia
- South-East Asia
- Rest of Asia Pacific
- Europe
- Germany
- Uk
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Middle East and Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East and Africa
- Competitive Landscape
- Mergers, Acquisitions, Joint Ventures, Collaborations, And Agreements
- Key Development
- Market Share (%) **/Ranking Analysis
- Strategies Adopted by Leading Players
- Mergers, Acquisitions, Joint Ventures, Collaborations, And Agreements
- Company Profiles
- Ge Healthcare
- Business Overview
- Company Snapshot
- Products Offered
- Key Development
- Philips Healthcare
- Siemens Healthiness
- Hitachi, Ltd.
- Canon, Inc.
- Lifelines Neuro Company, Llc
- Natus Medical Incorporated
- Hoffmann-La Roche Ag
- Fujifilm Holdings Corporation
- Mitsar Co., Ltd.
- Advanced Brain Monitoring, Inc.
- Thermo Fisher Scientific, Inc.
- Bio-Rad Laboratories
- Qiagen N.V.
- Nihon Kohden Corporation
- Ge Healthcare
- Introduction
LIST OF TABLES
TABLE 1Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL NEURODIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS), 2019-2028
TABLE 2Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL NEURODIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2019-2028
TABLE 3Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL NEURODIAGNOSTICS MARKET BY CONDITION (USD MILLIONS), 2019-2028
TABLE 4Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL NEURODIAGNOSTICS MARKET BY CONDITION (THOUSAND UNITS), 2019-2028
TABLE 5Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL NEURODIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2019-2028
TABLE 6Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL NEURODIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2019-2028
TABLE 7Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL NEURODIAGNOSTICS MARKET BY REGION (USD MILLIONS), 2019-2028
TABLE 8Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL NEURODIAGNOSTICS MARKET BY REGION (THOUSAND UNITS), 2019-2028
TABLE 9Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA NEURODIAGNOSTICS MARKET BY COUNTRY (USD MILLIONS), 2019-2028
TABLE 10Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA NEURODIAGNOSTICS MARKET BY COUNTRY (THOUSAND UNITS), 2019-2028
TABLE 11Â Â Â Â Â Â Â Â Â Â Â Â Â US NEURODIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS), 2019-2028
TABLE 12Â Â Â Â Â Â Â Â Â Â Â Â Â US NEURODIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2019-2028
TABLE 13Â Â Â Â Â Â Â Â Â Â Â Â Â US NEURODIAGNOSTICS MARKET BY CONDITION (USD MILLIONS), 2019-2028
TABLE 14Â Â Â Â Â Â Â Â Â Â Â Â Â US NEURODIAGNOSTICS MARKET BY CONDITION (THOUSAND UNITS), 2019-2028
TABLE 15Â Â Â Â Â Â Â Â Â Â Â Â Â US NEURODIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2019-2028
TABLE 16Â Â Â Â Â Â Â Â Â Â Â Â Â US NEURODIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2019-2028
TABLE 17Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA NEURODIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS), 2019-2028
TABLE 18Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA NEURODIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2019-2028
TABLE 19Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA NEURODIAGNOSTICS MARKET BY CONDITION (USD MILLIONS), 2019-2028
TABLE 20Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA NEURODIAGNOSTICS MARKET BY CONDITION (THOUSAND UNITS), 2019-2028
TABLE 21Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA NEURODIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2019-2028
TABLE 22Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA NEURODIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2019-2028
TABLE 23Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO NEURODIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS), 2019-2028
TABLE 24Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO NEURODIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2019-2028
TABLE 25Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO NEURODIAGNOSTICS MARKET BY CONDITION (USD MILLIONS), 2019-2028
TABLE 26Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO NEURODIAGNOSTICS MARKET BY CONDITION (THOUSAND UNITS), 2019-2028
TABLE 27Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO NEURODIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2019-2028
TABLE 28Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO NEURODIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2019-2028
TABLE 29Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA NEURODIAGNOSTICS MARKET BY COUNTRY (USD MILLIONS), 2019-2028
TABLE 30Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA NEURODIAGNOSTICS MARKET BY COUNTRY (THOUSAND UNITS), 2019-2028
TABLE 31Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL NEURODIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS), 2019-2028
TABLE 32Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL NEURODIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2019-2028
TABLE 33Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL NEURODIAGNOSTICS MARKET BY CONDITION (USD MILLIONS), 2019-2028
TABLE 34Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL NEURODIAGNOSTICS MARKET BY CONDITION (THOUSAND UNITS), 2019-2028
TABLE 35Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL NEURODIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2019-2028
TABLE 36Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL NEURODIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2019-2028
TABLE 37Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA NEURODIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS), 2019-2028
TABLE 38Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA NEURODIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2019-2028
TABLE 39Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA NEURODIAGNOSTICS MARKET BY CONDITION (USD MILLIONS), 2019-2028
TABLE 40Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA NEURODIAGNOSTICS MARKET BY CONDITION (THOUSAND UNITS), 2019-2028
TABLE 41Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA NEURODIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2019-2028
TABLE 42Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA NEURODIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2019-2028
TABLE 43Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA NEURODIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS), 2019-2028
TABLE 44Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA NEURODIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2019-2028
TABLE 45Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA NEURODIAGNOSTICS MARKET BY CONDITION (USD MILLIONS), 2019-2028
TABLE 46Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA NEURODIAGNOSTICS MARKET BY CONDITION (THOUSAND UNITS), 2019-2028
TABLE 47Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA NEURODIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2019-2028
TABLE 48Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA NEURODIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2019-2028
TABLE 49Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA NEURODIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS), 2019-2028
TABLE 50Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA NEURODIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2019-2028
TABLE 51Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA NEURODIAGNOSTICS MARKET BY CONDITION (USD MILLIONS), 2019-2028
TABLE 52Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA NEURODIAGNOSTICS MARKET BY CONDITION (THOUSAND UNITS), 2019-2028
TABLE 53Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA NEURODIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2019-2028
TABLE 54Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA NEURODIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2019-2028
TABLE 55Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA-PACIFIC NEURODIAGNOSTICS MARKET BY COUNTRY (USD MILLIONS), 2019-2028
TABLE 56Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA-PACIFIC NEURODIAGNOSTICS MARKET BY COUNTRY (THOUSAND UNITS), 2019-2028
TABLE 57Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA NEURODIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS), 2019-2028
TABLE 58Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA NEURODIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2019-2028
TABLE 59Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA NEURODIAGNOSTICS MARKET BY CONDITION (USD MILLIONS), 2019-2028
TABLE 60Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA NEURODIAGNOSTICS MARKET BY CONDITION (THOUSAND UNITS), 2019-2028
TABLE 61Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA NEURODIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2019-2028
TABLE 62Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA NEURODIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2019-2028
TABLE 63Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA NEURODIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS), 2019-2028
TABLE 64Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA NEURODIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2019-2028
TABLE 65Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA NEURODIAGNOSTICS MARKET BY CONDITION (USD MILLIONS), 2019-2028
TABLE 66Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA NEURODIAGNOSTICS MARKET BY CONDITION (THOUSAND UNITS), 2019-2028
TABLE 67Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA NEURODIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2019-2028
TABLE 68Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA NEURODIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2019-2028
TABLE 69Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN NEURODIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS), 2019-2028
TABLE 70Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN NEURODIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2019-2028
TABLE 71Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN NEURODIAGNOSTICS MARKET BY CONDITION (USD MILLIONS), 2019-2028
TABLE 72Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN NEURODIAGNOSTICS MARKET BY CONDITION (THOUSAND UNITS), 2019-2028
TABLE 73Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN NEURODIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2019-2028
TABLE 74Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN NEURODIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2019-2028
TABLE 75Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA NEURODIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS), 2019-2028
TABLE 76Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA NEURODIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2019-2028
TABLE 77Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA NEURODIAGNOSTICS MARKET BY CONDITION (USD MILLIONS), 2019-2028
TABLE 78Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA NEURODIAGNOSTICS MARKET BY CONDITION (THOUSAND UNITS), 2019-2028
TABLE 79Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA NEURODIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS), 2019-2028
TABLE 80Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA NEURODIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2019-2028
TABLE 81Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA NEURODIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2019-2028
TABLE 82Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA NEURODIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2019-2028
TABLE 83Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA NEURODIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS), 2019-2028
TABLE 84Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA NEURODIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2019-2028
TABLE 85Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA NEURODIAGNOSTICS MARKET BY CONDITION (USD MILLIONS), 2019-2028
TABLE 86Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA NEURODIAGNOSTICS MARKET BY CONDITION (THOUSAND UNITS), 2019-2028
TABLE 87Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA NEURODIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2019-2028
TABLE 88Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA NEURODIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2019-2028
TABLE 89Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA NEURODIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS), 2019-2028
TABLE 90Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA NEURODIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2019-2028
TABLE 91Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA NEURODIAGNOSTICS MARKET BY CONDITION (USD MILLIONS), 2019-2028
TABLE 92Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA NEURODIAGNOSTICS MARKET BY CONDITION (THOUSAND UNITS), 2019-2028
TABLE 93Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA NEURODIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2019-2028
TABLE 94Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA NEURODIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2019-2028
TABLE 95Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC NEURODIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS), 2019-2028
TABLE 96Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC NEURODIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2019-2028
TABLE 97Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC NEURODIAGNOSTICS MARKET BY CONDITION (USD MILLIONS), 2019-2028
TABLE 98Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC NEURODIAGNOSTICS MARKET BY CONDITION (THOUSAND UNITS), 2019-2028
TABLE 99Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC NEURODIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2019-2028
TABLE 100Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC NEURODIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2019-2028
TABLE 101Â Â Â Â Â Â Â Â Â Â Â EUROPE NEURODIAGNOSTICS MARKET BY COUNTRY (USD MILLIONS), 2019-2028
TABLE 102Â Â Â Â Â Â Â Â Â Â Â EUROPE NEURODIAGNOSTICS MARKET BY COUNTRY (THOUSAND UNITS), 2019-2028
TABLE 103Â Â Â Â Â Â Â Â Â Â Â GERMANY NEURODIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS), 2019-2028
TABLE 104Â Â Â Â Â Â Â Â Â Â Â GERMANY NEURODIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2019-2028
TABLE 105Â Â Â Â Â Â Â Â Â Â Â GERMANY NEURODIAGNOSTICS MARKET BY CONDITION (USD MILLIONS), 2019-2028
TABLE 106Â Â Â Â Â Â Â Â Â Â Â GERMANY NEURODIAGNOSTICS MARKET BY CONDITION (THOUSAND UNITS), 2019-2028
TABLE 107Â Â Â Â Â Â Â Â Â Â Â GERMANY NEURODIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2019-2028
TABLE 108Â Â Â Â Â Â Â Â Â Â Â GERMANY NEURODIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2019-2028
TABLE 109Â Â Â Â Â Â Â Â Â Â Â UK NEURODIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS), 2019-2028
TABLE 110Â Â Â Â Â Â Â Â Â Â Â UK NEURODIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2019-2028
TABLE 111Â Â Â Â Â Â Â Â Â Â Â UK NEURODIAGNOSTICS MARKET BY CONDITION (USD MILLIONS), 2019-2028
TABLE 112Â Â Â Â Â Â Â Â Â Â Â UK NEURODIAGNOSTICS MARKET BY CONDITION (THOUSAND UNITS), 2019-2028
TABLE 113Â Â Â Â Â Â Â Â Â Â Â UK NEURODIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2019-2028
TABLE 114Â Â Â Â Â Â Â Â Â Â Â UK NEURODIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2019-2028
TABLE 115Â Â Â Â Â Â Â Â Â Â Â FRANCE NEURODIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS), 2019-2028
TABLE 116Â Â Â Â Â Â Â Â Â Â Â FRANCE NEURODIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2019-2028
TABLE 117Â Â Â Â Â Â Â Â Â Â Â FRANCE NEURODIAGNOSTICS MARKET BY CONDITION (USD MILLIONS), 2019-2028
TABLE 118Â Â Â Â Â Â Â Â Â Â Â FRANCE NEURODIAGNOSTICS MARKET BY CONDITION (THOUSAND UNITS), 2019-2028
TABLE 119Â Â Â Â Â Â Â Â Â Â Â FRANCE NEURODIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2019-2028
TABLE 120Â Â Â Â Â Â Â Â Â Â Â FRANCE NEURODIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2019-2028
TABLE 121Â Â Â Â Â Â Â Â Â Â Â ITALY NEURODIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS), 2019-2028
TABLE 122Â Â Â Â Â Â Â Â Â Â Â ITALY NEURODIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2019-2028
TABLE 123Â Â Â Â Â Â Â Â Â Â Â ITALY NEURODIAGNOSTICS MARKET BY CONDITION (USD MILLIONS), 2019-2028
TABLE 124Â Â Â Â Â Â Â Â Â Â Â ITALY NEURODIAGNOSTICS MARKET BY CONDITION (THOUSAND UNITS), 2019-2028
TABLE 125Â Â Â Â Â Â Â Â Â Â Â ITALY NEURODIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2019-2028
TABLE 126Â Â Â Â Â Â Â Â Â Â Â ITALY NEURODIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2019-2028
TABLE 127Â Â Â Â Â Â Â Â Â Â Â SPAIN NEURODIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS), 2019-2028
TABLE 128Â Â Â Â Â Â Â Â Â Â Â SPAIN NEURODIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2019-2028
TABLE 129Â Â Â Â Â Â Â Â Â Â Â SPAIN NEURODIAGNOSTICS MARKET BY CONDITION (USD MILLIONS), 2019-2028
TABLE 130Â Â Â Â Â Â Â Â Â Â Â SPAIN NEURODIAGNOSTICS MARKET BY CONDITION (THOUSAND UNITS), 2019-2028
TABLE 131Â Â Â Â Â Â Â Â Â Â Â SPAIN NEURODIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2019-2028
TABLE 132Â Â Â Â Â Â Â Â Â Â Â SPAIN NEURODIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2019-2028
TABLE 133Â Â Â Â Â Â Â Â Â Â Â RUSSIA NEURODIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS), 2019-2028
TABLE 134Â Â Â Â Â Â Â Â Â Â Â RUSSIA NEURODIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2019-2028
TABLE 135Â Â Â Â Â Â Â Â Â Â Â RUSSIA NEURODIAGNOSTICS MARKET BY CONDITION (USD MILLIONS), 2019-2028
TABLE 136Â Â Â Â Â Â Â Â Â Â Â RUSSIA NEURODIAGNOSTICS MARKET BY CONDITION (THOUSAND UNITS), 2019-2028
TABLE 137Â Â Â Â Â Â Â Â Â Â Â RUSSIA NEURODIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2019-2028
TABLE 138Â Â Â Â Â Â Â Â Â Â Â RUSSIA NEURODIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2019-2028
TABLE 139Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE NEURODIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS), 2019-2028
TABLE 140Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE NEURODIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2019-2028
TABLE 141Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE NEURODIAGNOSTICS MARKET BY CONDITION (USD MILLIONS), 2019-2028
TABLE 142Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE NEURODIAGNOSTICS MARKET BY CONDITION (THOUSAND UNITS), 2019-2028
TABLE 143Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE NEURODIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2019-2028
TABLE 144Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE NEURODIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2019-2028
TABLE 145Â Â Â Â Â Â Â Â Â Â Â MIDDLE EAST AND AFRICA NEURODIAGNOSTICS MARKET BY COUNTRY (USD MILLIONS), 2019-2028
TABLE 146Â Â Â Â Â Â Â Â Â Â Â MIDDLE EAST AND AFRICA NEURODIAGNOSTICS MARKET BY COUNTRY (THOUSAND UNITS), 2019-2028
TABLE 147Â Â Â Â Â Â Â Â Â Â Â UAE NEURODIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS), 2019-2028
TABLE 148Â Â Â Â Â Â Â Â Â Â Â UAE NEURODIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2019-2028
TABLE 149Â Â Â Â Â Â Â Â Â Â Â UAE NEURODIAGNOSTICS MARKET BY CONDITION (USD MILLIONS), 2019-2028
TABLE 150Â Â Â Â Â Â Â Â Â Â Â UAE NEURODIAGNOSTICS MARKET BY CONDITION (THOUSAND UNITS), 2019-2028
TABLE 151Â Â Â Â Â Â Â Â Â Â Â UAE NEURODIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2019-2028
TABLE 152Â Â Â Â Â Â Â Â Â Â Â UAE NEURODIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2019-2028
TABLE 153Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA NEURODIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS), 2019-2028
TABLE 154Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA NEURODIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2019-2028
TABLE 155Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA NEURODIAGNOSTICS MARKET BY CONDITION (USD MILLIONS), 2019-2028
TABLE 156Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA NEURODIAGNOSTICS MARKET BY CONDITION (THOUSAND UNITS), 2019-2028
TABLE 157Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA NEURODIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2019-2028
TABLE 158Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA NEURODIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2019-2028
TABLE 159Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA NEURODIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS), 2019-2028
TABLE 160Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA NEURODIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2019-2028
TABLE 161Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA NEURODIAGNOSTICS MARKET BY CONDITION (USD MILLIONS), 2019-2028
TABLE 162Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA NEURODIAGNOSTICS MARKET BY CONDITION (THOUSAND UNITS), 2019-2028
TABLE 163Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA NEURODIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2019-2028
TABLE 164Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA NEURODIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2019-2028
TABLE 165Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA NEURODIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS), 2019-2028
TABLE 166Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA NEURODIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2019-2028
TABLE 167Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA NEURODIAGNOSTICS MARKET BY CONDITION (USD MILLIONS), 2019-2028
TABLE 168Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA NEURODIAGNOSTICS MARKET BY CONDITION (THOUSAND UNITS), 2019-2028
TABLE 169Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA NEURODIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2019-2028
TABLE 170Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA NEURODIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2019-2028
LIST OF FIGURES
FIGURE 1Â Â Â Â Â Â Â Â Â Â Â Â Â MARKET DYNAMICS
FIGURE 2Â Â Â Â Â Â Â Â Â Â Â Â Â MARKET SEGMENTATION
FIGURE 3Â Â Â Â Â Â Â Â Â Â Â Â Â REPORT TIMELINES: YEARS CONSIDERED
FIGURE 4Â Â Â Â Â Â Â Â Â Â Â Â Â DATA TRIANGULATION
FIGURE 5Â Â Â Â Â Â Â Â Â Â Â Â Â BOTTOM-UP APPROACH
FIGURE 6Â Â Â Â Â Â Â Â Â Â Â Â Â TOP-DOWN APPROACH
FIGURE 7Â Â Â Â Â Â Â Â Â Â Â Â Â RESEARCH FLOW
FIGURE 8Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL NEURODIAGNOSTICS MARKET BY PRODUCT, USD MILLION, 2019-2028
FIGURE 9Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL NEURODIAGNOSTICS MARKET BY CONDITION, USD MILLION, 2019-2028
FIGURE 10Â Â Â Â Â Â Â Â Â Â GLOBAL NEURODIAGNOSTICS MARKET BY END USER, USD MILLION, 2019-2028
FIGURE 11Â Â Â Â Â Â Â Â Â Â GLOBAL NEURODIAGNOSTICS MARKET BY REGION, USD MILLION, 2019-2028
FIGURE 12          PORTER’S FIVE FORCES MODEL
FIGURE 13Â Â Â Â Â Â Â Â Â Â GLOBAL NEURODIAGNOSTICS MARKET BY PRODUCT, 2020
FIGURE 14Â Â Â Â Â Â Â Â Â Â GLOBAL NEURODIAGNOSTICS MARKET BY CONDITION 2020
FIGURE 15Â Â Â Â Â Â Â Â Â Â GLOBAL NEURODIAGNOSTICS MARKET BY END USER 2020
FIGURE 16Â Â Â Â Â Â Â Â Â Â NEURODIAGNOSTICS MARKET BY REGION 2020
FIGURE 17Â Â Â Â Â Â Â Â Â Â MARKET SHARE ANALYSIS
FIGURE 18Â Â Â Â Â Â Â Â Â Â GE HEALTHCARE: COMPANY SNAPSHOT
FIGURE 19Â Â Â Â Â Â Â Â Â Â PHILIPS HEALTHCARE: COMPANY SNAPSHOT
FIGURE 20Â Â Â Â Â Â Â Â Â Â SIEMENS HEALTHINESS: COMPANY SNAPSHOT
FIGURE 21Â Â Â Â Â Â Â Â Â Â HITACHI, LTD.: COMPANY SNAPSHOT
FIGURE 22Â Â Â Â Â Â Â Â Â Â CANON, INC.: COMPANY SNAPSHOT
FIGURE 23Â Â Â Â Â Â Â Â Â Â LIFELINES NEURO COMPANY, LLC: COMPANY SNAPSHOT
FIGURE 24Â Â Â Â Â Â Â Â Â Â NATUS MEDICAL INCORPORATED: COMPANY SNAPSHOT
FIGURE 25Â Â Â Â Â Â Â Â Â Â F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT
FIGURE 26Â Â Â Â Â Â Â Â Â Â FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
FIGURE 27Â Â Â Â Â Â Â Â Â Â MITSAR CO., LTD.: COMPANY SNAPSHOT
FIGURE 28Â Â Â Â Â Â Â Â Â Â ADVANCED BRAIN MONITORING, INC.: COMPANY SNAPSHOT
FIGURE 29Â Â Â Â Â Â Â Â Â Â THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
FIGURE 30Â Â Â Â Â Â Â Â Â Â BIO-RAD LABORATORIES: COMPANY SNAPSHOT
FIGURE 31Â Â Â Â Â Â Â Â Â Â QIAGEN N.V.: COMPANY SNAPSHOT
FIGURE 32Â Â Â Â Â Â Â Â Â Â NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT
In-Depth Database
Our Report’s database covers almost all topics of all regions over the Globe.
Recognised Publishing Sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales
support.
Safe & Secure
Complete secure payment
process.